This study provided important complementary findings to previous investigations about the effect of mtROS and NLRP3 inflammasome on cutaneous inflammation, highlighting potential targets for effective treatment of inflammation‐related skin disorders. The gene discussed is NLRP3; the disease is skin disorder.